US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 12.570
  • +0.540+4.49%
Close Dec 31 16:00 ET
  • 12.560
  • -0.010-0.08%
Post 20:01 ET
1.31BMarket Cap-4.60P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rocket Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 28.450K--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 28.450K--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Rocket Pharmaceuticals Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:54 ET

  • 8-K: Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

    Nov 7, 2024 16:29 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:37 ET

  • 8-K: Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

    Aug 5, 2024 16:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      94.12%

    • Hold

      5.88%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data